This can be attributed to the various benefits offered by these therapeutic modalities, such as ease of administration, higher biological efficacy, enhanced potent immunogenicity and versatile delivery platforms at reduced toxicity levels.
To get a sample copy of the latest market report, visit
https://www.rootsanalysis.com/reports/mrna-therapeutics-and-vaccines-market/request-sample.html
The financial opportunity within the mRNA therapeutics and mRNA vaccines market has been analyzed across the following segments:
- Routes of Administration
- Intradermal
- Intravenous
- Intranasal
- Others
- Therapeutic Area
- Infectious Diseases
- Oncological Disorders
- Other Disorders
Key Geographical Regions
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and North Africa
The mRNA Therapeutics and mRNA Vaccines Market, 2022-2035 report features the following companies, which we identified to be key players in this domain:
- Arcturus Therapeutics
- BioNTech and Pfizer
- CureVac
- Gennova
- Moderna
- Walvax
Table of Contents
- Preface
- Executive Summary
- Introduction
- Market Overview
- Competitive Landscape
- Company Competitiveness Analysis
- Drug Profiles
- Big Pharma Initiatives
- Start-Up Health Indexing
- Clinical Trial Analysis
- Partnerships and Collaborations
- Funding and Investment Analysis
- Patent Analysis
- Market Forecast and Opportunity Analysis
- Market Forecast and Opportunity Analysis
- Conclusion
- Appendix 1: Tabulated Data
- Appendix 2: List of Companies and Organizations
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/mrna-therapeutics-and-vaccines-market.html
You may also be interested in the following titles:
You may also like to learn what our experts are sharing in Roots educational series:
CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
